Skip to main content

TD Asset Management Inc

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1056053 Toronto, A6

Position in REGN

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$271,137,146
-$35,721,316 QoQ
Shares Held
350,923
-11.7% QoQ
Ownership
0.335%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TD Asset Management Inc holds $1,314,505,240 across 121 Biotechnology names. REGN ranks #1 (20.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
350,923 $271,137,146

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $271,137,146 350,923
2025-12-31 $306,858,462 397,552
2025-09-30 $210,437,419 374,264
2025-06-30 $169,499,925 322,857
2025-03-31 $223,177,291 351,887
2024-12-31 $256,003,565 359,389
2024-09-30 $346,979,632 330,067
2024-06-30 $369,484,341 351,545
2024-03-31 $259,401,642 269,511
2023-12-31 $90,036,142 102,513
2023-09-30 $148,352,530 180,267
2023-06-30 $78,780,007 109,639
2023-03-31 $92,137,143 112,134
2022-12-31 $74,071,770 102,665
2022-09-30 $63,611,633 92,342
2022-06-30 $51,602,102 87,294
2022-03-31 $56,878,626 81,439
2021-12-31 $51,558,555 81,642
2021-09-30 $48,419,241 80,008
2021-06-30 $45,123,329 80,788
2021-03-31 $37,228,547 78,684
2020-12-31 $36,647,758 75,858
2020-09-30 $41,822,283 74,712
2020-06-30 $43,314,987 69,454
2020-03-31 $29,865,769 61,164